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Introduction
Phenethylamines and tryptamines are two classes of drugs that act at serotonin (5-HT) receptors and can produce hallucinations; in general, agonists from these two classes have similar but not identical behavioral and neurochemical effects. For example, many phenethylamines bind relatively non-selectively to 5-HT 2A and 5-HT 2C receptors and have comparatively lower (e.g., 1000-fold) affinity for other (e.g., 5-HT 1A ) 5-HT receptors. Tryptamines, on the other hand, often display higher affinity than phenethylamines for 5-HT 1A receptors (for reviews, see Nichols, 2004; Fantegrossi et al., 2008a ) and comparatively lower affinity for 5-HT 2A and 5-HT 2C receptors. Despite differences between phenethylamines and tryptamines in their binding selectivity for different 5-HT receptors, with few exceptions (e.g., Winter et al., 2000) agonists from these chemical classes have similar effects that appear to be mediated predominantly by 5-HT 2A receptors (e.g., Vollenweider et al., 1998) .
Drug discrimination is used to study receptor mechanisms that mediate the effects of drugs from a variety of pharmacologic classes. Many drugs with hallucinogenic effects in humans have agonist actions at 5-HT receptors and among those drugs, the discriminative stimulus effects of the phenethylamine 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) have been studied extensively in rodents (Glennon on et al., 1982; Fiorella et al., 1995a) and more recently in non-human primates (Li et al., 2008) . Converging lines of evidence indicate that despite the non-selective binding of DOM to 5-HT 2A and 5-HT 2C receptors, the discriminative stimulus effects of DOM appear to be mediated predominantly by 5-HT 2A receptors inasmuch as drugs that are antagonists at 5-HT 2A receptors often block the discriminative stimulus effects of This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on as DOI: 10.1124 at ASPET Journals on January 15, 2018 jpet.aspetjournals.org Downloaded from JPET #145458 6 DOM (e.g., Glennon and Rosecrans, 1983) . Moreover, the ability of drugs to antagonize the discriminative stimulus of DOM is positively correlated with binding affinity at 5-HT 2A receptors (Fiorella et al., 1995b) . However, there are conditions under which other receptors appear to play a role in the discriminative stimulus effects of DOM. For example, the non-selective 5-HT 2A/2C receptor agonist MK-212 substitutes for the discriminative stimulus effects of DOM in rats, and this effect of MK-212 is not fully antagonized by the 5-HT 2A receptor antagonist pirenpirone (Fiorella et al., 1995c) .
Collectively, these data suggest that other (e.g., 5-HT 2C ) receptors might play a role, directly or by modulation, in the discriminative stimulus effects of DOM and related 5-HT receptor agonists.
This study investigated the receptor mechanisms that mediate the discriminative stimulus effects of DOM and related drugs in rhesus monkeys. Each of three 5-HT receptor agonists was studied alone and in combination with each of three other drugs that are known to have antagonist actions at 5-HT 2A receptors: MDL 100907, ketanserin and ritanserin. Schild analysis has been used to examine receptor mechanisms for drugs acting at other receptors (Dykstra et al., 1988; Dykstra, 1990; France et al., 1990; Gerak and France, 2007) receptor agonists studied included DOM, 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7), and dipropyltryptamine (DPT). 2C-T-7 is a "designer" phenethylamine with hallucinogenic activity and high affinity at 5-HT 2A and 5-HT 2C receptors; however, the behavioral effects of 2C-T-7, including discriminative stimulus effects in non-human primates (Li et al., 2008) , appear to be mediated by 5-HT 2A receptors (Fantegrossi et al., 2005) . DPT, a tryptamine with hallucinogenic activity, recently was shown to have agonist activity at 5-HT 2A and 5-HT 1A receptors (Li et al., 2007; Fantegrossi et al., 2008b 
Methods
Subjects
Four adult rhesus monkeys weighing between 4 kg and 8 kg and previously trained to discriminate between saline and 0.32 mg/kg DOM (Li et al., 2008) 
Apparatus
During experimental sessions, subjects were seated in chairs (Model R001, Primate Products, Miami, FL) that provided restraint at the neck and arms and were placed within ventilated, sound-attenuating chambers. Chambers were equipped with response panels, each containing two stimulus lights and two response levers. The feet of monkeys were placed in shoes that were mounted to the front of chairs and equipped with brass electrodes to which a brief (250 ms, 3 mA) electric shock could be delivered from a.c. generators. Experiments were controlled and data recorded with a microprocessor and commercially available interface (Med Associates Inc., East Fairfield, VT).
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For drug training sessions, monkeys received an injection of 0.32 mg/kg DOM (s.c.) prior to one cycle followed by one sham (no injection) cycle. For vehicle training sessions monkeys received an injection of saline (s.c.) prior to one cycle followed by between one and five sham (no injection) cycles. Monkeys had previously satisfied the following criteria for 5 consecutive or 6 of 7 sessions (Li et al., 2008) : at least 80% of the total responses on the correct lever; and fewer than 5 responses (one FR requirement) on the incorrect lever prior to completion of the FR on the correct lever. Thereafter, monkeys were tested every third day provided that the testing criteria were satisfied during intervening training sessions. If monkeys failed to satisfy these criteria testing was postponed until the criteria were satisfied for two consecutive training sessions. Test sessions were similar to training sessions except that 5 consecutive responses on either lever postponed shock and increasing doses of drug were administered across cycles. For substitution studies, saline was administered in the first cycle followed by increasing doses of drug in subsequent cycles with the cumulative dose increasing by 0.25 or 0.5 log units per cycle. Drugs were studied up to doses that occasioned greater than 80% responding on the DOM lever. For antagonism studies, a single dose of antagonist was administered 5 min prior to the start of the first cycle.
Data Analyses
Drug discrimination data are expressed as a percentage of the total responses made on the DOM-paired lever averaged among four monkeys (± 1 SEM) and plotted as a function of dose. Rate of lever pressing is plotted as the average (± 1 SEM) number of responses per second on both levers. The control response rate is the average of the five vehicle training sessions before the test. Doses of test drugs to occasion 50% drug lever responding (ED 50 ) and 95% confidence limits (95% CL) were estimated using interpolation or linear regression using the portion of the dose-effect curve spanning 50% drug-lever responding. Dose ratios were determined for each monkey by dividing the ED 50 values for each agonist (DOM, 2C-T-7, and DPT) studied in combination with an antagonist (MDL100907, ketanserin, and ritanserin) by the ED 50 values for each agonist studied alone. Schild analyses were conducted as described previously (e.g., Li et al., 2008) using the method of Arunlakshana and Schild (1959) . Schild plots were constructed by plotting the log of the dose ratio (agonist with antagonist divided by agonist alone) -1 as a function of the negative log dose of antagonist (moles/kg). Straight lines were simultaneously fitted to This confidence limits (CL) with unconstrained slopes and, when appropriate, with slopes constrained to -1 (unity) were determined for each agonist and antagonist combination.
Slopes of Schild plots were considered to conform to unity when the 95% CL included -1 and did not include 0 (e.g., Paronis and Bergman, 1999) .
Drugs
The compounds used in this study were as follows: 1-(2,5-dimethoxy-4- DOM and 2C-T-7 were similar in potency and both were 4-fold more potent than DPT.
None of the compounds markedly altered rate of lever pressing at the doses studied 
Discussion
Reliable stimulus control between DOM and saline was maintained in rhesus monkeys responding under a two-choice, multiple-cycle, cumulative-dosing procedure and the potency of DOM under these conditions was similar to its potency determined when the same monkeys responded under a single-cycle, acute-dosing procedure (Li et al., 2008) . Under this multiple-cycle, cumulative-dosing procedure 2C-T-7 and DPT also increased responding on the DOM associated lever with potencies similar to their potencies under the single-cycle, acute-dosing procedure (Li et al., 2008) . One general feature of drug discrimination procedures is pharmacological selectivity such that, in general, only drugs that share a mechanism of action with the training drug occasion responding on the drug-associated lever. In that regard, the apparent qualitative similarity in discriminative stimulus effects among these three compounds is consistent with actions at 5-HT 2A receptors. While DPT also binds to 5-HT 1A receptors and 2C-T-7 has similar affinity for 5-HT 2A and 5-HT 2C receptors (Fantegrossi et al., 2005) , results of these substitution studies indicate that agonist activity at 5-HT 2A receptors accounts for the DOM-like discriminative stimulus effects of these drugs.
Drugs with affinity for and no apparent efficacy at 5-HT 2A receptors can attenuate the discriminative stimulus effects of DOM and related agonists in rats (Glennon et al., 1983 ) and in non-human primates (Li et al., 2008) . Similarly in the current study, drugs Schild analysis has been used to evaluate the behavioral effects of drugs acting at various different receptors including opioid France et al., 1990) , GABA A (Paronis and Bergman, 1999) , and 5-HT 1A receptors (Koek et al., 2000) ; however, this approach has not been used widely to examine the behavioral effects of drugs acting at 5-HT 2A receptors. Despite the challenges inherent with this analysis (e.g., Kenakin, 1982) , particularly in vivo when assumptions (e.g., equilibrium) can not be confirmed, remarkably orderly data can be obtained with this approach using behavioral data (Dykstra et al., 1988; Paronis and Bergman, 1999) . Similarly in the current study, the dose-response curves of each agonist were shifted to the right in an orderly doserelated manner by each of the antagonists. Moreover, for each drug combination the Schild analysis yielded slopes that were not significantly different from unity (-1), a result that is consistent with a simple, competitive, and reversible interaction, likely at a single 5-HT receptor subtype (e.g., 5-HT 2A ).
One value of Schild analysis is that the role of a particular receptor in the observed response can be confirmed quantitatively by comparing families of doseresponse curves for combinations of agonists and antagonists that vary in selectivity for different receptors. Each of the agonists used in this study (DOM, 2C-T-7 and DPT) has activity at 5-HT 2A receptors, but each also has activity at other receptors. Similarly, each of the antagonists used in this study (MDL 100907, ketanserin, and (Fig. 3) and the estimated apparent pA 2 values (Table 1) , the potency of each antagonist was remarkably similar with each of three different agonists. For example, the (unconstrained) apparent pA 2 values for ritanserin in combination with DOM, 2C-T-7 and DPT were 7.67, 7.76 and 7.76, respectively.
Constraining the slope of the Schild plot to unity (-1) had little effect on the absolute value of the apparent pA 2 values or on the high degree of consistency among these values across agonists (Table 1) , and this was the case for all three antagonists. Collectively, these results strongly suggest that a single receptor type mediates the effects of all three agonists and antagonists under these in vivo conditions and, therefore, and that affinity for and efficacy at other receptors types does not and that the interaction of these drugs with that receptor type is simple, competitive and reversible.
To the extent that only one receptor type mediates the effects of drugs under the conditions used in this discrimination study, the relative potency or affinity of these drugs for that receptor should predict their effects in this assay. Indeed, that appears to be the case both for agonists and for antagonists. DOM and 2C-T-7 have similar potency, and both are 3-fold more potent than DPT, in producing head twitching in mice (Fantegrossi et al., 2005 (Fantegrossi et al., , 2008b , an effect that is thought to be mediated by 5-HT 2A receptors. Based on apparent pA 2 values, ketanserin and ritanserin have very similar potency in antagonizing the discriminative stimulus effects of each agonist, being 10-17 fold less potent than MDL100907 in this regard. This potency relationship among these three This article has not been copyedited and formatted. The final version may differ from this version. antagonists parallels their relative potencies in blocking DOI-induced head twitching (Table 2) This article has not been copyedited and formatted. The final version may differ from this version. 
